An educational intervention to reduce the use of potentially inappropriate medications among older adults (EMPOWER study): protocol for a cluster randomized trial

Philippe Martin, Robyn Tamblyn, Sara Ahmed, Cara Tannenbaum, Philippe Martin, Robyn Tamblyn, Sara Ahmed, Cara Tannenbaum

Abstract

Background: Currently, far too many older adults consume inappropriate prescriptions, which increase the risk of adverse drug reactions and unnecessary hospitalizations. A health education program directly informing patients of prescription risks may promote inappropriate prescription discontinuation in chronic benzodiazepine users.

Methods/design: This is a cluster randomized controlled trial using a two-arm parallel-design. A total of 250 older chronic benzodiazepine users recruited from community pharmacies in the greater Montreal area will be studied with informed consent. A participating pharmacy with recruited participants represents a cluster, the unit of randomization. For every four pharmacies recruited, a simple 2:2 randomization is used to allocate clusters into intervention and control arms. Participants will be followed for 1 year. Within the intervention clusters, participants will receive a novel educational intervention detailing risks and safe alternatives to their current potentially inappropriate medication, while the control group will be wait-listed for the intervention for 6 months and receive usual care during that time period. The primary outcome is the rate of change in benzodiazepine use at 6 months. Secondary outcomes are changes in risk perception, self-efficacy for discontinuing benzodiazepines, and activation of patients initiating discussions with their physician or pharmacist about safer prescribing practices. An intention-to-treat analysis will be followed.The rate of change of benzodiazepine use will be compared between intervention and control groups at the individual level at the 6-month follow-up. Risk differences between the control and experimental groups will be calculated, and the robust variance estimator will be used to estimate the associated 95% confidence interval (CI). As a sensitivity analysis (and/or if any confounders are unbalanced between the groups), we will estimate the risk difference for the intervention via a marginal model estimated via generalized estimating equations with an exchangeable correlation structure.

Discussion: Targeting consumers directly as catalysts for engaging physicians and pharmacists in collaborative discontinuation of benzodiazepine drugs is a novel approach to reduce inappropriate prescriptions. By directly empowering chronic users with knowledge about risks, we hope to imitate the success of individually targeted anti-smoking campaigns.

Trial registration: ClinicalTrials.gov identifier: NCT01148186.

Figures

Figure 1
Figure 1
Study flow chart.

References

    1. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49:200–209. doi: 10.1046/j.1532-5415.2001.49042.x.
    1. Rancourt C, Moisan J, Baillargeon L, Verreault R, Laurin D, Gregoire JP. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004;4:9. doi: 10.1186/1471-2318-4-9.
    1. Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32:113–121. doi: 10.1111/j.1365-2710.2007.00793.x.
    1. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156:385–391.
    1. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am GeriatrSoc. 2012;2012(60):616–631.
    1. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825–1832. doi: 10.1001/archinte.1991.00400090107019.
    1. Hanlon JT, Sloane RJ, Pieper CF. Association of adverse drug reactions with drug-drug and drug-disease interactions in frail older outpatients. Age Ageing. 2011;40:274–277. doi: 10.1093/ageing/afq158.
    1. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002–2012. doi: 10.1056/NEJMsa1103053.
    1. Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS. Potentially inappropriate medication use in the community-dwelling elderly: findings from the Medical Expenditure Panel Survey. JAMA. 1996;2001(286):2823–2829.
    1. Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash) 2002;42:847–857. doi: 10.1331/108658002762063682.
    1. Jano E, Aparasu RR. Healthcare outcomes associated with beers’ criteria: a systematic review. Ann Pharmacother. 2007;41:438–447. doi: 10.1345/aph.1H473.
    1. Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Liu GG, Perri M III. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care. 2007;45:472–476. doi: 10.1097/01.mlr.0000254571.05722.34.
    1. Canadian Institute for Health Information. Drug Claims by Seniors: An Analysis Focusing on Potentially Inappropriate Medication Use, 2000 to 2006. Ottawa: Canadian Institute for Health Information; 2007.
    1. Conseil du Médicament. Étude sur la prévalence d l’usage d’ordonnances potentiellement non appropriées (OPNA) chez les aînés du Québec, de 2000 à 2006. Québec: Gouvernement du Québec; 2009.
    1. Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf. 2004;3:485–493. doi: 10.1517/14740338.3.5.485.
    1. Allain H, Bentue-Ferrer D, Polard E, Akwa Y, Patat A. Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs Aging. 2005;22(9):749–765. doi: 10.2165/00002512-200522090-00004.
    1. Cotroneo A, Gareri P, Nicoletti N, Lacava R, Grassone D, Maina E, De Sarro G, Cabodi S. Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people. Arch Gerontol Geriatr. 2007;44(Suppl 1):121–124.
    1. Finkle WD, Der JS, Greenland S, Adams JL, Ridgeway G, Blaschke T, Wang Z, Dell RM, VanRiper KB. Risk of fractures requiring hospitalization after an initial prescription of zolpidem, alprazolam, lorazepam or diazepam in older adults. J Am Geriatr Soc. 2011;59(10):1883–1890. doi: 10.1111/j.1532-5415.2011.03591.x.
    1. Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol. 2002;22:285–293. doi: 10.1097/00004714-200206000-00009.
    1. Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging. 2012;29(8):639–658.
    1. Billioti de Gage S, Bégaud B, Bazin F, Verdoux H, Dartigues JF, Pérès K, Kurth T, Pariente A. Benzodiazepine use and risk of dementia: prospective population based study. BMJ. 2012;345:e6231. doi: 10.1136/bmj.e6231.
    1. Cook JM, Biyanova T, Masci C, Coyne JC. Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: a qualitative study. J Gen Intern Med. 2007;22:1094–1100. doi: 10.1007/s11606-007-0205-5.
    1. Damestoy N, Collin J, Lalande R. Prescribing psychotropic medication for elderly patients: some physicians’ perspectives. Can Med Assoc J. 1999;161:143–145.
    1. Fick DM, Maclean JR, Rodriguez NA, Short L, Heuvel RV, Waller JL, Rogers RL. A randomized study to decrease the use of potentially inappropriate medications among community-dwelling older adults in a southeastern managed care organization. Am J Manag C. 2004;10:761–768.
    1. Allard J, Hebert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. Can Med Assoc J. 2001;164:1291–1296.
    1. Solomon DH, Hashimoto H, Daltroy L, Liang MH. Techniques to improve physicians’ use of diagnostic tests: a new conceptual framework. J Amer Med Assoc. 1998;280:2020–2027. doi: 10.1001/jama.280.23.2020.
    1. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, Bero L, Grilli R, Harvey E, Oxman A, O'Brien MA. Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39:II2–II45.
    1. Baker R, Farooqi A, Tait C, Walsh S. Randomised controlled trial of reminders to enhance the impact of audit in general practice on management of patients who use benzodiazepines. Qual Health Care. 1997;6:14–18. doi: 10.1136/qshc.6.1.14.
    1. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, Cowper PA, Landsman PB, Cohen HJ, Feussner JR. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428–437. doi: 10.1016/S0002-9343(97)89519-8.
    1. Hood JC, Lemberger M, Steward RB. Promoting appropriate therapy in a long-term care facility. J Am Health Care Assoc. 1975;1:10–13.
    1. Tamai IY, Rubenstein LZ, Josephson KR, Yamauchi JA. Impact of computerized drug profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drug Intel Clin Phar. 1987;21:890–895.
    1. Owens NJ, Sherburne NJ, Silliman RA, Fretwell MD. The Senior Care Study. The optimal use of medications in acutely ill older patients. J Am Geriatr Soc. 1990;38:1082–1087.
    1. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. Br Med J. 2001;323:1340–1343. doi: 10.1136/bmj.323.7325.1340.
    1. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drug Aging. 2003;20:817–832. doi: 10.2165/00002512-200320110-00003.
    1. Pimlott NJ, Hux JE, Wilson LM, Kahan M, Li C, Rosser WW. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. Can Med Assoc J. 2003;168:835–839.
    1. Rahme E, Choquette D, Beaulieu M, Bessette L, Joseph L, Toubouti Y, LeLorier J. Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population. Am J Med. 2005;118:1262–1270. doi: 10.1016/j.amjmed.2005.03.026.
    1. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, Whitehead C. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing. 2004;33:612–617. doi: 10.1093/ageing/afh213.
    1. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriat Psychiat Pharm. 2004;2:257–264.
    1. Coleman EA, Grothaus LC, Sandhu N, Wagner EH. Chronic care clinics: a randomized controlled trial of a new model of primary care for frail older adults. J Am Geriatr Soc. 1999;47:775–783.
    1. Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J, Francis SD, Branch LG, Lindblad CI, Artz M, Weinberger M, Feussner JR, Cohen HJ. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116:394–401. doi: 10.1016/j.amjmed.2003.10.031.
    1. Saltvedt I, Spigset O, Ruths S, Fayers P, Kaasa S, Sletvold O. Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. Eur J Clin Pharmacol. 2005;61:921–928. doi: 10.1007/s00228-005-0046-2.
    1. Strandberg TE, Pitkala KH, Berglind S, Nieminen MS, Tilvis RS. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomized, controlled trial. Am Heart J. 2006;152:585–592. doi: 10.1016/j.ahj.2006.02.006.
    1. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. J Am Med Assoc. 1998;280:1249–1252. doi: 10.1001/jama.280.14.1249.
    1. Tamblyn R, Huang A, Perreault R, Jacques A, Roy D, Hanley J, McLeod P, Laprise R. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. Can Med Assoc J. 2003;169:549–556.
    1. Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, Breteler MH, van den Hoogen HJ, Mulder J, Zitman FG. Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice. Fam Pract. 2006;23:65–72.
    1. Vicens C, Fiol F, Llobera J, Campoamor F, Mateu C, Alegret S, Socías I. Withdrawal from long-term benzodiazepine use: randomised trial in family practice. Br J Gen Pract. 2006;56:958–963.
    1. Stewart R, Niessen WJ, Broer J, Snijders TA, Haaijer-Ruskamp FM, Meyboom-De JB. General Practitioners reduced benzodiazepine prescriptions in an intervention study: a multilevel application. J Clin Epidemiol. 2007;60:1076–1084.
    1. Gorgels W, Oude Voshaar R, Mol A, Van De Lisdonk E, Mulder J, Van Den Hoogen H, Van Balkom A, Breteler M, Zitman F. A benzodiazepine discontinuation programme does not increase the frequency of contacts with the family practice. Scand J Prim Health. 2008;26:74–79. doi: 10.1080/02813430801999121.
    1. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–699. doi: 10.1111/j.1532-5415.2005.53221.x.
    1. Ives C. Instructional-design theories and models, volume III: building a common knowledge base (book review) Educ Tech Soc. 2010;13:219–221.
    1. Bem DJ. Self-perception: An alternative interpretation of cognitive dissonance phenomena. Psychol Rev. 1967;74:183–200.
    1. Wood V. What is social comparison and how should we study it? Pers Soc Psychol B. 1996;22:520–537. doi: 10.1177/0146167296225009.
    1. Martin R, Suls J, Wheeler L. Ability evaluation by proxy: role of maximal performance and related attributes in social comparison. J Pers Soc Psychol. 2002;82:781–791.
    1. Sedikides C. Assessment, enhancement, and verification determinants of the self-evaluation process. J Pers Soc Psychol. 1993;65:317–338.
    1. Sedikides C, Strube M. Self-evaluation: To thine own self be good, to thine own self be sure, to thine own self be true, and to thine own self be better. Adv Exp Soc Psychol. 1997;29:209–269.
    1. Slovic P. Perception of risk. Science. 1987;236:280–285. doi: 10.1126/science.3563507.
    1. Brewer NT, Weinstein ND, Cuite CL, Herrington JE. Risk perceptions and their relation to risk behavior. Ann Behav Med. 2004;27:125–130. doi: 10.1207/s15324796abm2702_7.
    1. Pligt J. Perceived risk and vulnerability as predictors of precautionary behaviour. Brit J Health Psych. 1998;3:1–14. doi: 10.1111/j.2044-8287.1998.tb00551.x.
    1. Prochaska JO, Norcross JC, DiClemente CC. Changing for good: the revolutionary program that explains the six stages of change and teaches you how to free yourself from bad habits. New York: William Morrow and Company; 1994.
    1. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire (BMQ): the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1998;14:1–24.
    1. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–567. doi: 10.1016/S0022-3999(99)00057-4.
    1. Belanger L, Morin CM, Bastien C, Ladouceur R. Self-efficacy and compliance with benzodiazepine taper in older adults with chronic insomnia. Health Psychol. 2005;24:281–287.
    1. Rhoads M, Thai A. Physician acceptance rate of pharmacist recommendations to reduce use of potentially inappropriate medications in the assisted living setting. Consult Pharm. 2003;18(3):241–247.
    1. Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, van den Hoogen HJ, Mulder J, Breteler MH, Zitman FG. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. Drug Alcohol Depend. 2005;78:49–56. doi: 10.1016/j.drugalcdep.2004.09.001.
    1. Niessen WJM, Stewart RE, Broer J, Haaijer-Ruskamp FM. Vermindering van gebruik van benzodiazepinen door een brief van de eigenhuisartsaanchronischegebruikers [Reduction in the consumption of benzodiazepines due to a letter to chronic users from their own general practitioner] Ned TijdschrGeneeskd. 2005;149:356–361.
    1. Bashir K, King M, Ashworth M. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. Br J Gen Prac. 1994;44(386):408–412.
    1. Holden D, Hughes IM, Tree A. Benzodiazepine prescribing and withdrawal for 3234 patients in 15 general practices. Fam Pract. 1994;11:358–362. doi: 10.1093/fampra/11.4.358.
    1. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol. 2006;35(5):1292–1300. doi: 10.1093/ije/dyl129.
    1. Ukoumunne OC, Forbes AB, Carlin JB, Gulliford MC. Comparison of the risk difference, risk ratio and odds ratio scales for quantifying the unadjusted intervention effect in cluster randomized trials. Stat Med. 2008;27:5143–5155. doi: 10.1002/sim.3359.
    1. Craig P, Dieppe P, Macintyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluationg complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655. doi: 10.1136/bmj.a1655.
    1. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469–2475. doi: 10.1001/jama.288.19.2469.
    1. Sminia H, Van Nistelrooij A. Strategic management and organizational development: planned change in a public sector organization. J Change Manag. 2006;6:99–113. doi: 10.1080/14697010500523392.
    1. Lemmens V, Oenema A, Knut IK, Brug J. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev. 2008;17:535–544. doi: 10.1097/CEJ.0b013e3282f75e48.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel